NASDAQ : MLAB
Mesa Laboratories, Inc. — Key statistics
Technology · Scientific & Technical Instruments · United States
Last price 133.03 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 744.42M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 692.71M |
| Enterprise Value | 821.83M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | Nov 30, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 5.60M |
| Shares Outstanding | 5.60M |
| Shares Change (YoY) | +3.27% |
| Shares Change (QoQ) | +3.84% |
| Owned by Insiders (%) | 3.08% |
| Owned by Institutions (%) | 87.57% |
| Float | 4.95M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 143.80 |
| Forward PE | 56.33 |
| PS Ratio | 2.86 |
| Forward PS | 2.79 |
| PB Ratio | 3.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.53 |
| P/OCF Ratio | 12.85 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 175.90 |
| EV / Sales | 3.38 |
| EV / EBITDA | 18.58 |
| EV / EBIT | 37.56 |
| EV / FCF | 15.97 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.79 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 3.05 |
| Debt / FCF | 3.05 |
| Interest Coverage | 2.07 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 2.66% |
| Return on Assets (ROA) | 3.29% |
| Return on Invested Capital (ROIC) | 3.58% |
| Return on Capital Employed (ROCE) | 6.21% |
| Weighted Average Cost of Capital (WACC) | 8.95% |
| Revenue Per Employee | $348,291 |
| Profits Per Employee | $6,695 |
| Employee Count | 717 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 3.23 |
Taxes
| Measure | Value |
|---|
| Income Tax | 4.56M |
| Effective Tax Rate | 48.69% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +73.47% |
| 50-Day Moving Average | 128.52 |
| 200-Day Moving Average | 104.36 |
| Relative Strength Index (RSI) | 44.47 |
| Average Volume (20 Days) | 87,231 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 390,561 |
| Short Previous Month | 447,048 |
| Short % of Shares Out | 6.98% |
| Short % of Float | 7.90% |
| Short Ratio (days to cover) | 3.34 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 249.73M |
| Gross Profit | 160.34M |
| Operating Income | 22.48M |
| Pretax Income | 9.36M |
| Net Income | 4.80M |
| EBITDA | 45.44M |
| EBIT | 22.48M |
| Earnings Per Share (EPS) | $0.86 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 32.24M |
| Total Debt | 161.35M |
| Net Cash | -129.11M |
| Net Cash Per Share | -$23.07 |
| Equity (Book Value) | 188.76M |
| Book Value Per Share | 33.73 |
| Working Capital | 45.53M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 55.67M |
| Capital Expenditures | -2.80M |
| Depreciation & Amortization | 22.96M |
| Net Borrowing | -38.47M |
| Free Cash Flow | 52.87M |
| FCF Per Share | $9.45 |
Margins
| Measure | Value |
|---|
| Gross Margin | 64.21% |
| Operating Margin | 9.00% |
| Pretax Margin | 3.75% |
| Profit Margin | 1.92% |
| EBITDA Margin | 18.19% |
| EBIT Margin | 9.00% |
| FCF Margin | 21.17% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 74.35% |
| FCF Payout Ratio | 6.77% |
| Buyback Yield | -3.27% |
| Shareholder Yield | -2.77% |
| Earnings Yield | 0.70% |
| FCF Yield | 7.39% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $117.50 |
| Price Target Difference | -5.08% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.49 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |